Fredun Pharmaceuticals Ltd — Updates, 31-05-2025: Company Update

Fredun Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year. The company reported strong growth with total income rising 41.8% YoY to Rs. 167.4 Cr in Q4 and 30.7% YoY to Rs. 456.3 Cr for FY25. EBITDA grew 56.2% YoY to Rs. 17.4 Cr in Q4 and 41.6% YoY to Rs. 55.1 Cr for FY25, while profit after tax increased 39.7% YoY to Rs. 7.1 Cr in Q4 and 33.2% YoY to Rs. 20.8 Cr for the year. Key developments include launching Freossi Large Animals products for livestock, expanding Freossi pet care division internationally to Sri Lanka, winning a Rs. 15-18 Cr tender from Tamil Nadu Medical Services Corporation, and achieving a record order book of Rs. 213 Cr. The focus is on growing the Non-Pharma business to drive future profitability through innovative healthcare and animal care solutions.